Pharming Group NV PHARM-NL:Euronext Amsterdam

*Data is delayed | EUR
Last | 3:56 PM CEST
0.7515quote price arrow up+0.0065 (+0.87%)
Volume
1,768,133
52 week range
0.66 - 1.03
Loading...
  • Open0.739
  • Day High0.758
  • Day Low0.7345
  • Prev Close0.745
  • 52 Week High1.03
  • 52 Week High Date05/26/21
  • 52 Week Low0.66
  • 52 Week Low Date12/02/21

Key Stats

  • Market Cap490.95M
  • Shares Out651.44M
  • 10 Day Average Volume2.73M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-3.03

KEY STATS

  • Open0.739
  • Day High0.758
  • Day Low0.7345
  • Prev Close0.745
  • 52 Week High1.03
  • 52 Week High Date05/26/21
  • 52 Week Low0.66
  • 52 Week Low Date12/02/21
  • Market Cap490.95M
  • Shares Out651.44M
  • 10 Day Average Volume2.73M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-3.03

RATIOS/PROFITABILITY

  • EPS (TTM)0.02
  • P/E (TTM)34.16
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pharming Group NV

There is no recent news for this security.

Profile

MORE
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1...
Paul Sekhri
Non-Executive Independent Chairman of the Board
Sijmen de Vries M.D.
Chief Executive Officer, Executive Director
Mireille Sanders
Chief Operations Officer
Jeroen Wakkerman
Chief Financial Officer
Address
Darwinweg 24
Leiden
2333 CR
Netherlands